Spectral AI, Inc. (MDAI) Stock

Spectral AI, Inc. (MDAI) is a Healthcare stock trading at $1.80 (as of 2026-06-18), with a market capitalization of $65.88M and a trailing P/E of -3.6. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Spectral AI, Inc. (MDAI) is an AI company focused on medical diagnostics in wound care, including burns and diabetic foot ulcers. Its DeepView predictive diagnostic device is designed to provide clinicians an objective assessment of a wound’s healing potential before treatment decisions.

Valuation — source: SEC EDGAR (first-party)
Price$1.80
Market Cap$65.88M
P/E Ratio-3.6
EV / EBITDA-5.3
Price / Book-6.57
Price / Sales3.42
DCF Value (model)$-5.00
DCF Upside vs Price-377.0%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$19.65M
Net Margin-38.5%
Return on Equity157.5%
Debt / Equity-0.51
Current Ratio0.75
Revenue Growth (YoY)-33.6%
EPS Growth (YoY)-65.9%
Financial Health — source: SEC EDGAR
Altman Z-Score-2.85 (distress)
Valuation vs Sector & Industry
Stock P/E-3.6
Sector P/E (Healthcare)21.0
Industry P/E (Medical Equipment)31.7
vs Sector-117.0%
vs Industry-111.2%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderHudson Bay Capital Management LP ($2.17M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryMedical Equipment
CEOVincent Stanley Capone
Employees78
CountryUS
IPO Date2021-04-06

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

  • Nephros, Inc. (NEPH)
  • NeurAxis, Inc. (NRXS)
  • Alpha Pro Tech, Ltd. (APT)
  • NeuroOne Medical Technologies Corporation (NMTC)
  • Baird Medical Investment Holdings Limited (BDMD)
  • Precipio, Inc. (PRPO)
  • Precision Optics Corporation, Inc. (POCI)
  • Myomo, Inc. (MYO)
MDAI earnings history · MDAI institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.